Follow this preprint
The prevalence of SARS-CoV-2 infection and uptake of COVID-19 antiviral treatments during the BA.2/BA.2.12.1 surge, New York City, April-May 2022
Saba A Qasmieh, View ORCID ProfileMcKaylee M Robertson, Chloe A Teasdale, Sarah G Kulkarni, Margaret McNairy, View ORCID ProfileLuisa N. Borrell, View ORCID ProfileDenis Nash
doi: https://doi.org/10.1101/2022.05.25.22275603
Now published in Communications Medicine doi: 10.1038/s43856-023-00321-w
Saba A Qasmieh
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); New York, NY, USA
2Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY); New York, NY, USA
McKaylee M Robertson
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); New York, NY, USA
2Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY); New York, NY, USA
Chloe A Teasdale
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); New York, NY, USA
2Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY); New York, NY, USA
Sarah G Kulkarni
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); New York, NY, USA
Margaret McNairy
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); New York, NY, USA
3Center for Global Health and Division of General Internal Medicine, Weill Cornell Medicine, New York, NY, USA
Luisa N. Borrell
2Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY); New York, NY, USA
Denis Nash
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); New York, NY, USA
2Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY); New York, NY, USA

Posted May 26, 2022.
The prevalence of SARS-CoV-2 infection and uptake of COVID-19 antiviral treatments during the BA.2/BA.2.12.1 surge, New York City, April-May 2022
Saba A Qasmieh, McKaylee M Robertson, Chloe A Teasdale, Sarah G Kulkarni, Margaret McNairy, Luisa N. Borrell, Denis Nash
medRxiv 2022.05.25.22275603; doi: https://doi.org/10.1101/2022.05.25.22275603
Now published in Communications Medicine doi: 10.1038/s43856-023-00321-w
Subject Area
Reviews and Context
1
Comment
0
TRIP Peer Reviews
3
Community Reviews
0
Automated Services
47
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (418)
- Allergy and Immunology (740)
- Anesthesia (217)
- Cardiovascular Medicine (3180)
- Dermatology (268)
- Emergency Medicine (469)
- Epidemiology (13156)
- Forensic Medicine (18)
- Gastroenterology (879)
- Genetic and Genomic Medicine (4988)
- Geriatric Medicine (458)
- Health Economics (764)
- Health Informatics (3143)
- Health Policy (1115)
- Hematology (418)
- HIV/AIDS (988)
- Medical Education (463)
- Medical Ethics (122)
- Nephrology (512)
- Neurology (4736)
- Nursing (252)
- Nutrition (701)
- Oncology (2437)
- Ophthalmology (692)
- Orthopedics (272)
- Otolaryngology (335)
- Pain Medicine (316)
- Palliative Medicine (88)
- Pathology (524)
- Pediatrics (1265)
- Primary Care Research (539)
- Public and Global Health (7301)
- Radiology and Imaging (1641)
- Respiratory Medicine (954)
- Rheumatology (468)
- Sports Medicine (411)
- Surgery (528)
- Toxicology (66)
- Transplantation (226)
- Urology (196)